The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: a potential disease-modifying OA drug
<p><strong>Objective</strong></p> To investigate the role of endogenous TSG-6 in human osteoarthritis (OA) and assess the disease-modifying potential of a TSG-6-based biological treatment in cell, explant and animal models of OA. <p><strong>Design</strong>&l...
Main Authors: | Drummond, SP, Bartnik, E, Kouvatsos, N, Scott, JL, Dyer, DP, Thomson, JM, Price, AJ, Anand, S, Biant, LC, Leeuw, T, Herrmann, M, Milner, CM, Day, AJ |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Elsevier
2023
|
Podobne knjige/članki
-
TSG-6 Acts Synergisticly with OPG to Inhibit Bone Resorption
od: Mahoney, D, et al.
Izdano: (2008) -
TSG-6, new regulator of bone remodelling
od: Mahoney, D, et al.
Izdano: (2007) -
Metal Ion-Dependent Heavy Chain Transfer Activity of TSG-6 Mediates Assembly of the Cumulus-Oocyte Matrix
od: Briggs, DC, et al.
Izdano: (2016) -
TSG‐6 is weakly chondroprotective in murine OA but does not account for FGF2‐mediated joint protection
od: Zhu, L, et al.
Izdano: (2020) -
TSG‐6 Is Weakly Chondroprotective in Murine OA but Does not Account for FGF2‐Mediated Joint Protection
od: Linyi Zhu, et al.
Izdano: (2020-10-01)